Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction
Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction
Purpose Propensity score (PS) methods aim to control for confounding by balancing confounders between exposed and unexposed subjects
with the same PS. PS balancemeasures have been compared in simulated data but limited in empirical data. Our objective was to compare balance
measures in clinical data and assessed the association between long-acting inhalation beta-agonist (LABA) use and myocardial infarction.
Methods We estimated the relationship between LABA use and myocardial infarction in a cohort of adults with a diagnosis of asthma or
chronic obstructive pulmonary disorder from the Utrecht General Practitioner Research Network database. More than two thousand PS models,
including information on the observed confounders age, sex, diabetes, cardiovascular disease and chronic obstructive pulmonary disorder status,
were applied. The balance of these confounders was assessed using the standardised difference (SD), Kolmogorov–Smirnov (KS) distance and
overlapping coefficient. Correlations between these balance measures were calculated. In addition, simulation studies were performed to assess
the correlation between balance measures and bias.
Results LABA use was not related to myocardial infarction after conditioning on the PS (median heart rate = 1.14, 95%CI = 0.47–2.75).
When using the different balance measures for selecting a PS model, similar associations were obtained. In our empirical data, SD and
KS distance were highly correlated balance measures (r = 0.92). In simulations, SD, KS distance and overlapping coefficient were similarly
correlated to bias (e.g. r = 0.55, r = 0.52 and r =?0.57, respectively, when conditioning on the PS).
Conclusions We recommend using the SD or the KS distance to quantify the balance of confounder distributions when applying PS methods.
propensity score, confounding, adverse effects, pharmacoepidemiology
1130-1137
Groenwold, Rolf H. H.
bb790d51-8871-4f87-9420-53bde208930f
de Vries, Frank
10245a32-6083-4feb-9d20-7e7db0f358b1
de Boer, Anthonius
18179869-03fb-447a-87bf-6d9f395c7dee
Pestman, Wiebe R.
bd49954d-95e9-439b-afb6-e8015449e25a
Rutten, Frans R.
2bfb6751-d5d9-414f-be7e-7d041542c72c
Hoes, Arno W.
1550255e-3684-4681-912b-c3f62a1dd82e
Klugel, Olaf H.
43c417f9-cfde-4581-8c43-7c835e5838a9
November 2011
Groenwold, Rolf H. H.
bb790d51-8871-4f87-9420-53bde208930f
de Vries, Frank
10245a32-6083-4feb-9d20-7e7db0f358b1
de Boer, Anthonius
18179869-03fb-447a-87bf-6d9f395c7dee
Pestman, Wiebe R.
bd49954d-95e9-439b-afb6-e8015449e25a
Rutten, Frans R.
2bfb6751-d5d9-414f-be7e-7d041542c72c
Hoes, Arno W.
1550255e-3684-4681-912b-c3f62a1dd82e
Klugel, Olaf H.
43c417f9-cfde-4581-8c43-7c835e5838a9
Groenwold, Rolf H. H., de Vries, Frank, de Boer, Anthonius, Pestman, Wiebe R., Rutten, Frans R., Hoes, Arno W. and Klugel, Olaf H.
(2011)
Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction.
Pharmacoepidemiology and Drug Safety, 20 (11), .
(doi:10.1002/pds.2251).
(PMID:21953948)
Abstract
Purpose Propensity score (PS) methods aim to control for confounding by balancing confounders between exposed and unexposed subjects
with the same PS. PS balancemeasures have been compared in simulated data but limited in empirical data. Our objective was to compare balance
measures in clinical data and assessed the association between long-acting inhalation beta-agonist (LABA) use and myocardial infarction.
Methods We estimated the relationship between LABA use and myocardial infarction in a cohort of adults with a diagnosis of asthma or
chronic obstructive pulmonary disorder from the Utrecht General Practitioner Research Network database. More than two thousand PS models,
including information on the observed confounders age, sex, diabetes, cardiovascular disease and chronic obstructive pulmonary disorder status,
were applied. The balance of these confounders was assessed using the standardised difference (SD), Kolmogorov–Smirnov (KS) distance and
overlapping coefficient. Correlations between these balance measures were calculated. In addition, simulation studies were performed to assess
the correlation between balance measures and bias.
Results LABA use was not related to myocardial infarction after conditioning on the PS (median heart rate = 1.14, 95%CI = 0.47–2.75).
When using the different balance measures for selecting a PS model, similar associations were obtained. In our empirical data, SD and
KS distance were highly correlated balance measures (r = 0.92). In simulations, SD, KS distance and overlapping coefficient were similarly
correlated to bias (e.g. r = 0.55, r = 0.52 and r =?0.57, respectively, when conditioning on the PS).
Conclusions We recommend using the SD or the KS distance to quantify the balance of confounder distributions when applying PS methods.
This record has no associated files available for download.
More information
e-pub ahead of print date: 23 September 2011
Published date: November 2011
Keywords:
propensity score, confounding, adverse effects, pharmacoepidemiology
Organisations:
Faculty of Health Sciences
Identifiers
Local EPrints ID: 208341
URI: http://eprints.soton.ac.uk/id/eprint/208341
ISSN: 1053-8569
PURE UUID: 9ac18f66-3ca0-46f1-871e-817647671775
Catalogue record
Date deposited: 18 Jan 2012 14:14
Last modified: 14 Mar 2024 04:43
Export record
Altmetrics
Contributors
Author:
Rolf H. H. Groenwold
Author:
Frank de Vries
Author:
Anthonius de Boer
Author:
Wiebe R. Pestman
Author:
Frans R. Rutten
Author:
Arno W. Hoes
Author:
Olaf H. Klugel
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics